IDEAYA Biosciences (IDYA) Other Non Operating Income (2018 - 2019)
IDEAYA Biosciences' (IDYA) quarterly Other Non Operating Income came in at $2000.0 in Q4 2019, down 66.67% quarter-over-quarter from $6000.0 in Q2 2019.
IDEAYA Biosciences (IDYA) Other Non Operating Income (2018 - 2019) Analysis & Trends
IDEAYA Biosciences has disclosed Other Non Operating Income across 2 years of filings, most recently posting $2000.0 for Q4 2019.
- Other Non Operating Income for Q4 2019 came in at $2000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $8000.0 (changed N/A YoY), and the FY2019 annual result was $8000.0, down 89.61% from the prior year.
- Other Non Operating Income came in at $2000.0 for Q4 2019 at IDEAYA Biosciences, down from $6000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $8000.0 in Q2 2018 to a low of $1000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 2,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 8,000.00 |